ERBB2 and breast cancer: To investigate if the composition of these ECT differed between BC molecular subtypes, we performed deconvolution of transcriptomic data from the METABRIC cohort (487 Lum A, 368 Lum B, 193 HER2 and 186 Basal-like TN BC) using BayesPrism74.